Targeting AR-positive breast cancer cells via drug repurposing approach-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Targeting AR-positive breast cancer cells via drug repurposing approach

Published:2024-02 Issue: Volume:108 Page:108007
ISSN:1476-9271
Container-title:Computational Biology and Chemistry
language:en
Short-container-title:Computational Biology and Chemistry

Author:

Dutta Parijat,Sen Plaboni^ORCID,Kandasamy Thirukumaran,Ghosh Siddhartha Sankar

Funder

Department of Biotechnology, Ministry of Science and Technology, India

Ministry of Electronics and Information technology

Indian Institute of Technology Guwahati

Publisher

Elsevier BV

Subject

Computational Mathematics,Organic Chemistry,Biochemistry,Structural Biology

Reference19 articles.

1. American Cancer Society. Breast cancer facts & figures 2019–2020. Am. Cancer Soc. 2019 Feb 15:1-44.

2. Specific morphological features predictive for the basal phenotype in grade 3 invasive ductal carcinoma of breast;Fulford;Histopathology,2006

3. Breast cancer treatment: a review;Waks;Jama,2019

4. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies;Lehmann;J. Clin. Investig.,2011

5. Clinical implications of androgen-positive triple-negative breast cancer;Brumec;Cancers,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP